A brief summary of what is in the news this week. BD
Glaxo to shutter 620-worker U.K. plant
The latest casualty of impending drug-patent expirations is a GlaxoSmithKline plant in Kent, England. The drugmaker says it will shutter the manufacturing facility by 2013, eliminating more than 600 jobs in the process.
For sale: Pfizer's Terre Haute factory
Nine months after halting production of its inhaled insulin and idling more than 600 workers at a plant near Terre Haute, drugmaker Pfizer Inc. is putting the massive factory up for sale.
Pfizer said today that it is seeking a buyer for the 580,000-square-foot site in Vigo County, which has undergone more than $300 million in upgrades since 1999.
Amylin lays off 340 as Byetta flags
The layoff pain in Pharma isn't limited to the big guns. Amylin Pharmaceuticals yesterday cut 340 staffers--some 25 percent of its workforce--to save $100 million a year. The San Diego drugmaker will be left with 1,800 workers.
Disappointing sales of Amylin's diabetes med, Byetta, prompted the staffing cuts, which will include positions in administration, operations and R&D, CEO Daniel Bradbury told the San Diego Union-Tribune.
0 comments :
Post a Comment